Godavari Biorefineries Limited secured a patent from the European Patent Office for its invention, “Pharmaceutical Composition and a Process to Prepare the Same.” The patent covers a pharmaceutical composition that combines novel anti-cancer compounds with a solubilising agent, along with a process for preparing the composition. The development strengthens the company’s oncology-focused intellectual property portfolio and expands its international presence in pharmaceutical research.
Enhancing Solubility and Bioavailability
The patented composition aims to improve the solubility and bioavailability of the active anti-cancer compounds. As a result, it could enhance their therapeutic potential and support the development of more effective treatment options. The composition has potential applications in treating various cancers, including breast and prostate cancers, particularly through oral administration. By addressing formulation challenges, the innovation could help improve the practical therapeutic use of promising anti-cancer compounds.
Strengthening Oncology Research Capabilities
Dr Sangeeta Srivastava, Executive Director, Godavari Biorefineries Limited, said that identifying a promising compound represents only one stage of oncology research. Equally important is developing a formulation that enables the compound to be effectively used for therapeutic applications. She added that the company’s research has focused on improving the solubility and bioavailability of these compounds, and the European patent represents an important recognition of this work.
European Patent Marks Key R&D Milestone
Samir Somaiya, Chairman and Managing Director of Godavari Biorefineries Limited, described the patent as an important milestone in the company’s innovation journey. According to Somaiya, the company’s approach to innovation focuses on advancing health, wellbeing and sustainability while creating long-term value. He said the company’s continued investment in research and development is helping it build capabilities beyond its traditional businesses and explore areas where science and technology can address important societal needs. He also highlighted the Sanskrit mantra ‘सर्वे सन्तु निरामयाः’, meaning ‘Health for All’, as a reflection of the broader purpose guiding the company’s innovation efforts.
Expanding Global Intellectual Property Portfolio
The European patent further strengthens Godavari Biorefineries’ international intellectual property footprint. Moreover, it reinforces the company’s efforts to protect its research and innovation across major global markets. As per the press release, as Godavari Biorefineries continues to invest in R&D, the latest patent expands its oncology-focused intellectual property portfolio and opens new possibilities for developing healthcare solutions with potential therapeutic applications.
